Home > News > AMSBIO:Xeno-Free and Endotoxin-Free Human Cytokines
Industry Updates New Products Supplier News Upcoming Events business web

AMSBIO:Xeno-Free and Endotoxin-Free Human Cytokines

Hits:1259   Date: 5/4/2015

AMSBIO has launched a complete new range of commonly used human cytokines and growth factors. Unlike most of other commercially available cytokine products, ActiveMax® cytokines are expressed exclusively in human cells under strict animal-free and xeno-free conditions. Therefore, they are uniquely suitable for human cell culture and assay development.

Endotoxin and other non–human components can provoke immune response in human systems. These contaminations are significant complicating factors for human cell culture experiments, in particular those relevant to human cell therapy or other clinical applications. AMSBIO ActiveMax® cytokines are exclusively produced in a serum-free, animal component-free and chemically defined cell culture system. These cytokines are absolutely xeno-free, and have an endotoxin level of less than 1.0 EU per microgram.

Human recombinant proteins expressed from bacteria, insect, or non-human mammalian cells often fall short in fully recapitulating the post-translational modifications of their native counterparts, largely due to lack of human-specific mechanisms in the hosts. Consequently, these proteins often demonstrate compromised biological properties. By contrast the bulk production of ActiveMax® cytokines relies entirely on the human cellular machinery provided by the HEK293 cells. As a result, AMSBIO cytokines retain their authentic post-translational processing, which translates into high bioactivity and stability. In addition, our HEKMax® production technology platform confers a very high level of target expression, which allows us to purify proteins without the use of artificially introduced tags. This true tag-free production brings the benefit of fully maintaining the proteins’ native conformation and biological properties, including ligand-receptor binding affinity, which may be affected by subtle charge/size changes caused by the addition of tags.

For further information on ActiveMax® cytokines available please visit www.amsbio.com/ActiveMax-Cytokines.aspx  or contact AMSBIO now on +44-1235-828200 / +1-949-768-8365 / info@amsbio.com

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology products and services for research and development in the medical, nutrition, cosmetics and energy industries. The AMSBIO range includes specialist antibodies, peptides and recombinant proteins. In addition the company is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as experts in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance screening outcomes and eventual prognosis. With a range of molecular detection reagents, and a significant Biorepository the company can also provide tissue DNA, RNA, protein and microarray products. Key research areas for these products include: Oncology, Regenerative Medicine, Environmental Analysis, Cytotoxicity Screening, Glycomics and Stem Cell Biology.

---------------------

Worldwide HQ

AMS Biotechnology (AMSBIO)
184 Milton Park
Abingdon
Oxon OX14 4SE
UK

Tel: +44-1235-828200
Fax: +44-1235-820482
Email:
info@amsbio.com  
Web
www.amsbio.com
 
North American HQ
 
AMSBIO LLC
1035 Cambridge Street
Cambridge
MA 02141
USA

Tel: +1.617.945.5033
Tel: +1.800.987.0985 (toll free)
Email:
info@amsbio.com  
Web
www.amsbio.com